scanX
Home
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

1,646.05
-66.95
(-3.91%)
Market Cap (₹ Cr.)
₹48,349
52 Week High
1,769.60
Book Value
₹278
52 Week Low
722.10
PE Ratio
PB Ratio
6.16
PE for Sector
39.11
PB for Sector
4.60
ROE
3.84 %
ROCE
7.97 %
Dividend Yield
0.15 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
6.58 %
Net Income Growth
-1,944.24 %
Cash Flow Change
-142.44 %
ROE
-2,463.08 %
ROCE
17.04 %
EBITDA Margin (Avg.)
-0.74 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
3,158
1,274
1,628
1,413
1,998
1,765
2,166
2,298
2,015
1,590
1,531
1,401
1,519
1,634
2,296
1,574
1,756
1,567
1,982
1,911
1,878
1,846
2,126
2,100
1,967
2,280
2,692
2,250
1,965
2,258
2,525
2,414
2,172
2,194
2,307
1,624
8,081
2,385
Expenses
2,203
819
1,130
1,066
1,416
1,066
1,390
1,347
1,629
1,195
1,107
1,120
1,166
1,088
1,288
1,283
1,319
1,190
1,409
1,403
1,406
1,174
1,567
1,442
1,494
1,585
1,721
1,523
1,624
1,478
1,826
1,723
2,380
1,691
1,810
1,575
1,651
1,698
EBITDA
955
455
498
347
582
699
775
951
385
396
424
281
354
546
1,008
291
437
377
573
508
471
672
559
657
473
695
971
727
341
780
699
691
-208
503
497
49
6,431
687
Operating Profit %
28 %
33 %
28 %
23 %
18 %
34 %
32 %
36 %
16 %
21 %
20 %
9 %
11 %
20 %
21 %
20 %
14 %
18 %
19 %
19 %
10 %
29 %
23 %
26 %
18 %
26 %
20 %
24 %
6 %
21 %
15 %
19 %
-27 %
19 %
17 %
-21 %
21 %
26 %
Depreciation
95
24
25
25
26
25
26
26
27
30
24
24
24
27
27
26
26
32
33
38
35
36
37
41
37
37
40
41
42
45
46
46
47
49
50
51
52
53
Interest
7
8
9
8
10
11
42
50
50
46
47
47
51
55
61
55
53
68
65
60
64
60
60
83
63
59
53
50
74
40
52
56
59
62
58
74
83
15
Profit Before Tax
853
423
464
314
546
662
707
875
308
320
353
210
279
463
921
210
358
277
475
411
373
576
462
533
373
598
878
637
225
696
601
589
-313
392
389
-76
6,295
618
Tax
182
85
92
51
118
143
152
195
146
68
58
33
60
76
192
31
85
60
71
72
66
101
80
93
69
105
125
141
40
110
88
104
85
39
9
-53
1,055
108
Net Profit
670
339
372
263
512
519
556
711
357
271
328
194
222
397
748
196
281
228
432
346
349
462
403
442
342
489
754
549
206
493
423
431
-137
272
302
-20
4,614
454
EPS in ₹
24.71
12.29
13.19
9.33
18.15
18.39
19.70
25.21
12.65
9.60
11.62
6.88
7.85
14.08
26.49
6.94
9.97
8.07
15.31
12.25
12.38
16.39
14.28
15.68
12.11
17.34
26.73
19.44
7.29
17.46
15.00
15.26
-4.87
9.63
10.72
-0.72
163.50
16.08
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
7,651
10,113
14,001
15,265
17,143
18,952
20,618
22,915
24,586
27,414
Fixed Assets
1,231
1,438
1,596
1,699
1,413
1,612
1,722
1,752
1,746
1,756
Current Assets
3,598
4,628
5,951
5,875
5,141
4,424
4,909
4,403
4,386
4,681
Capital Work in Progress
294
276
271
420
286
200
131
109
172
198
Investments
0
1,858
1,867
3,213
3,269
4,714
6,990
8,559
10,333
12,965
Other Assets
6,126
6,541
10,267
9,933
12,174
12,426
11,774
12,494
12,335
12,496
Total Liabilities
2,699
2,747
4,564
4,874
5,201
5,725
5,808
6,176
6,708
4,444
Current Liabilities
2,444
2,742
1,972
2,185
2,281
2,389
2,503
3,441
3,642
4,289
Non Current Liabilities
254
5
2,592
2,689
2,920
3,337
3,305
2,735
3,067
154
Total Equity
4,952
7,366
9,437
10,391
11,942
13,226
14,810
16,739
17,878
22,971
Reserve & Surplus
4,925
7,338
9,408
10,363
11,914
13,198
14,781
16,710
17,849
22,942
Share Capital
27
28
28
28
28
28
28
28
28
28
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-64
32
177
-75
79
-168
-73
14
64
35
Investing Activities
-176
-1,545
-2,580
-1,137
-2,256
-1,607
-1,235
-897
-432
3,197
Operating Activities
145
355
878
1,124
2,490
1,579
1,243
1,216
1,474
-495
Financing Activities
-32
1,223
1,879
-62
-155
-139
-81
-305
-978
-2,666
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
46.63 %
46.63 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.64 %
46.65 %
FIIs
25.84 %
26.82 %
25.93 %
24.18 %
24.12 %
24.23 %
23.14 %
23.20 %
22.46 %
25.52 %
24.80 %
23.71 %
21.38 %
20.98 %
DIIs
9.15 %
9.73 %
9.02 %
10.87 %
10.96 %
10.50 %
10.91 %
10.69 %
10.41 %
9.11 %
10.32 %
10.92 %
13.36 %
13.92 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
Public / Retail
18.38 %
16.82 %
18.40 %
18.31 %
18.27 %
18.63 %
19.27 %
19.43 %
20.45 %
18.68 %
18.20 %
18.69 %
18.58 %
18.41 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,836.00 4,47,691.91 42.46 49,887.17 12.06 9,648 42.62 61.03
Cipla
1,651.60 1,34,956.56 30.36 26,520.66 14.17 4,155 17.77 60.15
Zydus Life Science
1,079.95 1,11,727.19 26.80 19,831.50 13.82 3,831 30.78 34.07
Dr Reddys Laboratories
6,567.80 1,10,648.92 19.88 28,905.40 12.36 5,578 -0.90 36.38
Lupin
2,224.95 1,03,570.56 45.76 20,141.50 19.94 1,936 77.69 59.35
Mankind Pharma
2,395.60 98,296.04 50.09 10,615.63 19.57 1,942 9.89 53.00
Aurobindo Pharma
1,539.15 90,940.60 25.35 29,559.25 17.55 3,169 61.17 55.58
Alkem Laboratories
6,090.30 74,370.03 34.59 12,978.42 9.84 1,811 91.18 53.74
Glenmark Pharmaceuticals
1,646.05 48,348.71 - 12,653.09 6.58 -1,831 96.52 48.26
Biocon
363.65 45,082.53 28.88 15,621.20 35.25 1,298 478.78 48.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
48.26
ATR(14)
Volatile
43.36
STOCH(9,6)
Neutral
64.20
STOCH RSI(14)
Oversold
4.49
MACD(12,26)
Bearish
-14.36
ADX(14)
Strong Trend
49.53
UO(9)
Bearish
42.15
ROC(12)
Downtrend And Accelerating
-2.48
WillR(14)
Oversold
-84.33
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.